Research focus
About the research
Can pancreatic precursor lesions called IPMN be studied to prevent pancreatic cancer?
Read the full research overview
Peter Allen is a surgical oncologist with clinical and research training in pancreatic and hepatobiliary malignancy. Allen has been interested in the progression of pancreatic precursor lesions called intraductal papillary mucinous neoplasms. His research has focused on biomarker development to identify high-risk IPMN as well as studies evaluating the cause of this disease process. He is the PI of a first-in-human multi-center randomized chemoprevention trial for pancreatic cancer that is targeting patients with high-risk IPMN.
Selected publications
3 listedLong-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma
Annals of Surgical Oncology
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study
Surgery
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication
JAMA Surgery
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings